Arts and humanities research commercialisation and a new funding platform
Small Grants, Big Ideas: ARTiUM is a funding platform that allows users to directly support the next wave of arts and humanities research through donations to fund innovative academic projects. Durham University has launched a pilot of the digital platform to gauge interest and demonstrate proof of concept. Artium is set to revolutionise how foundational […]
Investors see the Magnitude of Wormgazer technology
Durham University spinout Magnitude Biosciences has secured over £706,000 in funding to drive development of its next-generation drug screening platform. Magnitude Biosciences is a specialist contract research organisation (CRO) in County Durham. It offers in vivo discovery of treatments for age-related conditions and other diseases using microscopic worms called C. elegans. The funding will enable […]
King’s Award for Durham spinout working to make railways safer
Durham University spinout company Geoptic, has been honoured with a King’s Award for Enterprise. The award recognises the company’s pioneering approach to assessing the condition and safety of railway tunnels. The King’s Awards are the highest official UK awards for British businesses. Railway safety The award for Geoptic, in the Innovation category, recognises the unique […]
Growth acceleration funding for the Durham spinout decarbonising construction
Durham University spinout Low Carbon Materials (LCM) has secured £3M growth acceleration funding. LCM is on a mission to decarbonise concrete and asphalt – huge contributors to the world’s carbon emissions. LCM designs and manufactures carbon-negative aggregates, the essential crushed stone, sand, or gravel components that give concrete and asphalt their strength and stability. The […]
The Durham spinout trialling new treatments for Motor Neurone Disease
Nevrargenics Limited, a Durham University spinout supported by Northern Accelerator, has got the green light to run a clinical trial. Andy Whiting is CEO of Nevrargenics Limited and an Emeritus Professor in the university’s Chemistry Department. Andy explained how his team is using new funding to discover new treatments and hopefully a cure for the […]
£1.5m investment in Lightox boosts development of innovative treatment to prevent oral cancer
A Durham University spinout has raised £1.5m investment to help develop a ground-breaking treatment for patients with early-stage oral cancer. LightOx, now based at The Biosphere at Newcastle Helix, has raised money to develop its lead candidate LXD191. LXD191 is an oral gel activated by a light device targeting a serious pre-cancerous condition called oral […]
From university research to a spinout hosting exciting royal visit
Prince William made a visit to Durham University spinout Low Carbon Materials (LCM) this week. His Royal Highness learned about how the Earthshot Prize finalists create their innovative, low-carbon construction materials. LCM spun out of Durham University in 2019, co-founded by Dr Natasha Boulding, Scott Bush and Dr Phil Buckley. The company develops materials that […]
New road material paves the way to net zero
A road resurfacing scheme in County Durham has used a new material which enables the creation of net zero asphalt. This UK first uses a material designed and manufactured by Low Carbon Materials (LCM). LCM is a Northern Accelerator-supported spinout from Durham University. Durham County Council and roads resurfacing partner Rainton Construction – part of […]
Magnitude Biosciences awarded £250,000 grant to continue pioneering work
Magnitude Biosciences Limited, a Durham University spin-out and specialist provider of C. elegans research services to the longevity, nutraceuticals, and pharmaceutical industries based in the North East of England, has been awarded a Future Economy Investor Partnerships grant of nearly £250,000 by Innovate UK. The grant will be matched by an investment from the North […]
Magnitude Biosciences secures £500k investment to accelerate business growth
Magnitude Magnitude Biosciences Limited has closed a fourth round of investment to accelerate the scaling of its business. The Durham University spin-out specialises in providing C. elegans research services to the longevity, nutraceuticals and pharmaceutical industries. The investment has been made in response to rapidly growing customer demand for Magnitude Biosciences’ services. The new funding […]